SPY334.33+2.22 0.67%
DIA273.90+1.90 0.70%
IXIC11,108.07+109.67 1.00%

Morgan Stanley Maintains Overweight on Nevro, Raises Price Target to $100

Morgan Stanley maintains Nevro (NYSE:NVRO) with a Overweight and raises the price target from $76 to $100.

Benzinga · -

Morgan Stanley maintains Nevro (NYSE:NVRO) with a Overweight and raises the price target from $76 to $100.